Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative neoplasms.
Fernández-Mercado
Marta
M
Cebrián
Virginia
V
Euba
Begoña
B
García-Granero
Marta
M
Calasanz
María J
MJ
Novo
Francisco J
FJ
Vizmanos
José L
JL
García-Delgado
Marina
M
D018899:CpG Islands; D019175:DNA Methylation; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D019337:Hematologic Neoplasms / Q000235:genetics*; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D022423:Myeloid Cells / Q000473:pathology; D017354:Point Mutation; D000071222:Suppressor of Cytokine Signaling 1 Protein; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins / Q000235:genetics*
C108944:SOCS1 protein, human; C106644:SOCS3 protein, human; D000071222:Suppressor of Cytokine Signaling 1 Protein; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins; D016044:Fusion Proteins, bcr-abl; C507924:JAK2 protein, human; D053614:Janus Kinase 2